In recent weeks, protests have grown across the United States and beyond against pharmaceutical giants, who have risen in the spotlight as their role in soaring drug prices is increasingly under scrutiny. This wave of dissent is now being dubbed “Pharmageddon” by activists, as the consequences are already becoming increasingly clear: pharmacies, already struggling in the wake of the pandemic, are now increasingly at risk of closure.
For months, many have blamed the high cost of prescription drugs on the pharmaceutical industry, and their monopolistic practices. Now, grassroots activists are taking their anger to the next level with organized protests aimed at bringing attention to what they describe as an “outrageous cost” to consumers.
The protests, which began in late August, began in response to news of more and more prescription drugs becoming dramatically more expensive. Reportedly, one company, Turing Pharmaceuticals, upped the price of one drug, Daraprim (used to treat infections in people with weakened immune systems), by 5,000%, a huge step that caused a public outcry and mass outrage.
Since then, protests have rapidly grown with hundreds of citizens gathering in various cities each day. Activities of the protesters include a range of activities including peaceful marches, picketing, and petition-signing campaigns. Their common message has been to demand more transparency and fairness in healthcare pricing from companies whose profits seem to be soaring with no regard for the economic impact on everyday Americans.
The growing trend of Pharmageddon has put a strain on pharmacies as the battle between the pharmaceutical industry and protesters ensures. Stressing out thousands of local small businesses, pharmacies are now facing an uphill battle to stay open as drug prices soar. This has made it difficult for them to pay for medications and hire additional staff to cope with the increased demand.
The current situation is dire for many community pharmacies, with some even closing their doors and giving up. Moreover, the threat that more closures, layoffs and reduced access to medications could quickly follow is a real possibility.
At this point, a compromise between individuals and the pharmaceutical industry seems necessary. Pharmacists are already doing their best to maintain operations, by negotiating with drug companies and clearing out the backlog of prescriptions, but it is not clear if those efforts will suffice in today’s market.
Ultimately, as Pharmageddon intensifies, it is becoming clear that both sides must come to the negotiating table and find some common ground. Only then, will it be possible to safeguard the future of local pharmacies and ensure Americans can still get the life-saving medications they need.
